Multicenter, Platform-type Clinical Study of Refractory/Recurrent Acute Myeloid Leukemia
Clinical trial NCT06265545 · RECRUITING
Trial details
- NCT number
- NCT06265545
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-22
- Primary completion
- 2028-01-30
- Enrollment
- 458
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.